pe
pep-10347 v1 CC-BY-SA-4.0

Experimental blood-sugar-regulating peptide (CHEMBL1222077)

An experimental peptide that switches on the body's blood-sugar-lowering pathway; not an approved drug.

statusbioassayed targetGLP-1R length27 aa refs5
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 5 / 5
prediction metrics openfold3-mlx 0.3.1
ipTM0.854
pTM0.723
avg pLDDT53.0
ranking score0.913
STRUCTURE · PEP-10347 × GLP-1R
ranking0.913
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
openfold3-mlx 0.3.1 · mmCIF ↓ download
sequence27 aa
151015202527
QGTFTSDYS KYLDERRAQ DFVQWLMNT
in the news 136 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
EC50 1.1 nM GPCRDB/ChEMBL
3-letter notation
Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr
recipeopenfold3-mlx 0.3.1
parametervalue
modelopenfold3-mlx 0.3.1
weights
hardwareapple_m4_base_16gb
mlx version
python
random seed
msa strategycolabfold
diffusion samples1
runtime419s
predicted bymlx@peptide
predicted at2026-04-25
citationbibtex
peptidemodel (2026). Experimental blood-sugar-regulating peptide (CHEMBL1222077) (pep-10347, v1). PeptideModel. https://peptidemodel.com/card/pep-10347
@peptide{pep10347,
  sequence = {QGTFTSDYSKYLDERRAQDFVQWLMNT},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 5 by signal overlap
clinical trials 0 trials · checked 2026-05-22
0
no registered clinical trials as of 2026-05-22; we'll re-check periodically
references 5 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use